Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

Scott A ReismanReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]Correspondence[email protected]

Sarabjit S GahirReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]

Chun-Yue I LeeReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]

Joel W ProkschReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]

Mitsumasa SakamotoReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]

Keith W WardReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]

Pages 1259-1270 | Published online: 17 Apr 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

LibyKTSpornMBSynthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic diseasePharmacol Rev2012644972100310.1124/pr.111.00484622966038
PubMed Web of Science ®Google Scholar
KerinsMJOoiAThe roles of NRF2 in modulating cellular iron homeo-stasisAntioxid Redox Signal2018291756177310.1089/ars.2017.717628793787
PubMed Web of Science ®Google Scholar
LiskCMcCordJBoseSNrf2 activation: a potential strategy for the prevention of acute mountain sicknessFree Radic Biol Med20136326427310.1016/j.freeradbiomed.2013.05.02423722164
PubMed Web of Science ®Google Scholar
WuKCCuiJYKlaassenCDBeneficial role of Nrf2 in regulating NADPH generation and consumptionToxicol Sci2011123259060010.1093/toxsci/kfr18321775727
PubMed Web of Science ®Google Scholar
HayesJDDinkova-KostovaATThe Nrf2 regulatory network provides an interface between redox and intermediary metabolismTrends Biochem Sci201439419921810.1016/j.tibs.2014.02.00224647116
PubMed Web of Science ®Google Scholar
LudtmannMHAngelovaPRZhangYAbramovAYDinkova-KostovaATNrf2 affects the efficiency of mitochondrial fatty acid oxidationBiochem J2014457341542410.1042/BJ2013086324206218
PubMed Web of Science ®Google Scholar
HolmstromKMBairdLZhangYNrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respirationBiol Open20132876177010.1242/bio.2013485323951401
PubMed Web of Science ®Google Scholar
HolmstromKMKostovRVDinkova-KostovaATThe multifaceted role of Nrf2 in mitochondrial functionCurr Opin Toxicol20161809110.1016/j.cotox.2016.10.00228066829
PubMedGoogle Scholar
ShanYSchoenfeldRAHayashiGFrataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich’s ataxia YG8R mouse modelAntioxid Redox Signal201319131481149310.1089/ars.2012.453723350650
PubMed Web of Science ®Google Scholar
AnzovinoAChiangSBrownBEHawkinsCLRichardsonDRHuangMLMolecular alterations in a mouse cardiac model of Friedreich ataxia: an impaired Nrf2 response mediated via upregulation of Keap1 and activation of the Gsk3beta axisAm J Pathol2017187122858287510.1016/j.ajpath.2017.08.02128935570
PubMed Web of Science ®Google Scholar
D’OriaVPetriniSTravagliniLFrataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neuronsInt J Mol Sci20131447853786510.3390/ijms1404785323574943
PubMed Web of Science ®Google Scholar
KraftADLeeJMJohnsonDAKanYWJohnsonJANeuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response elementJ Neurochem20069861852186510.1111/j.1471-4159.2006.04019.x16945104
PubMed Web of Science ®Google Scholar
Shekh-AhmadTEckelRDayalan NaiduSKEAP1 inhibition is neuroprotective and suppresses the development of epilepsyBrain201814151390140310.1093/brain/awy07129538645
PubMed Web of Science ®Google Scholar
PuccioHAnheimMTranchantCPathophysiogical and therapeutic progress in Friedreich ataxiaRev Neurol (Paris)2014170535536510.1016/j.neurol.2014.03.00824792433
PubMed Web of Science ®Google Scholar
AbetiRBaccaroAEsterasNGiuntiPNovel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich’s ataxia modelsFront Cell Neurosci20181218810.3389/fncel.2018.0018830065630
PubMed Web of Science ®Google Scholar
LynchDRFarmerJHauserLSafety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxiaAnn Clin Transl Neurol201961152610.1002/acn3.66030656180
PubMed Web of Science ®Google Scholar
ReismanSAGoldsberryARLeeCYTopical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteersBMC Dermatol2015151010.1186/s12895-015-0029-726170027
PubMedGoogle Scholar
ReismanSALeeCYMeyerCJProkschJWWardKWTopical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skinArch Dermatol Res2014306544745410.1007/s00403-013-1433-724362512
PubMed Web of Science ®Google Scholar
ReismanSAYeagerRLYamamotoMKlaassenCDIncreased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen speciesToxicol Sci20091081354710.1093/toxsci/kfn26719129213
PubMed Web of Science ®Google Scholar
CreelanBCGabrilovichDIGrayJESafety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumorsOnco Targets Ther2017104239425010.2147/OTT.S13699228919776
PubMed Web of Science ®Google Scholar
HanPQinZTangJRTA-408 protects kidney from ischemia-reperfusion injury in mice via activating Nrf2 and downstream GSH biosynthesis geneOxid Med Cell Longev20172017761218210.1155/2017/761218229435098
PubMed Web of Science ®Google Scholar
AbetiRUzunERenganathanIHondaTPookMAGiuntiPTargeting lipid peroxidation and mitochondrial imbalance in Friedreich’s ataxiaPharmacol Res20159934435010.1016/j.phrs.2015.05.01526141703
PubMed Web of Science ®Google Scholar
PaupeVDassaEPGoncalvesSImpaired nuclear Nrf2 trans-location undermines the oxidative stress response in Friedreich ataxiaPLoS One200941e425310.1371/journal.pone.000425319158945
PubMed Web of Science ®Google Scholar
WildACMulcahyRTRegulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defensesFree Radic Res200032428130110741850
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date